查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552865

心臟病診斷市場規模、佔有率、趨勢分析報告：按測試、按最終用途、按地區、細分市場預測，2024-2030 年

Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

心臟病診斷市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球心臟病診斷市場規模預計將達到 185.2 億美元。

預計 2024 年至 2030 年期間，心臟病診斷市場將以 8.2% 的複合年成長率成長。整體風險因素和疾病負擔仍然很高，使得心臟病診斷領域具有盈利的成長前景。這種成長主要是由於心臟疾病的高盛行率、吸煙增加、肥胖、不健康飲食的強化以及個體中高膽固醇的發病率，特別是在不斷成長的老年人口中。然而，移動心臟門診遙測心電圖（ECG）的醫療保險報銷較低以及心臟病發病率的逐漸下降預計將阻礙市場成長。

心臟病診斷市場包括測量心臟電活動的心電圖、提供心臟影像的超音波以及測量某些蛋白質（如肌鈣蛋白水平和心肌酵素）過度表達的血液測試，按產品分類為「其他」。 。由於技術進步和心電圖應用的增加，預計開發中國家的心電圖領域將呈現顯著成長。然而，對具有成本效益的快速血液檢測（如肌鈣蛋白和肌酸激酶 MB同功異構酵素(CK-MB)）的需求不斷成長，可能會在不久的將來獲得顯著的市場佔有率。本報告涵蓋的主要國家包括美國、加拿大、德國、英國、中國、印度、巴西、墨西哥、南非和中東。預計亞太地區將成為預測期內成長最快的地區。同時，北美預計將主導全球心臟病診斷市場。

心臟病診斷市場報告亮點

  • 據估計，北美將主導全球心臟病診斷市場。人們對心臟病及其原因和風險因素的認知不斷提高，以及對先進技術診斷的採用和接受程度的提高，預計將有助於市場的成長。
  • 預計亞太地區在預測期內將經歷最快的成長。這是因為在印度等某些發展中地區，心臟病負擔非常嚴重，每年有 240 萬人死於心臟病。由於心臟病患病率迅速上升，迫切需要採取意識提升的措施並採用先進的診斷方法，預計這將推動市場成長。
  • 肌鈣蛋白細分市場在血液檢測市場佔據主導地位，到 2023 年將佔 62.5% 的佔有率。肌鈣蛋白 T 是一種存在於心肌中的蛋白質，對於透過高度敏感的肌鈣蛋白 T 測試診斷心臟病至關重要。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章心臟病診斷市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 心臟病診斷市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 心臟病診斷市場：透過測試進行的估計和趨勢分析

  • 細分儀表板
  • 心臟病診斷市場：測試變異分析，2023 年和 2030 年
  • 心電圖
  • 驗血
  • 其他

第5章 心臟病診斷市場：依最終用途分類的估計和趨勢分析

  • 細分儀表板
  • 心臟病診斷市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 門診手術中心
  • 其他

第6章 心臟病診斷市場：區域估計與趨勢分析

  • 心臟病診斷市場佔有率（按地區），2023 年和 2030 年，十億美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • GE Healthcare
    • Hitachi Corporation
    • Koninklijke Philips NV
    • Midmark Corporation
    • F Hoffmann-La Roche Ltd
    • Schiller AG
    • Siemens Healthineers
    • Toshiba Corporation
    • Welch Allyn Inc
    • Astrazaneca PLC
簡介目錄
Product Code: GVR-1-68038-053-8

Heart Attack Diagnostics Market Growth & Trends:

The global heart attack diagnostics market size is expected to reach USD 18.52 billion by 2030, according to a new report by Grand View Research, Inc. The heart attack diagnostics market is anticipated to grow at a CAGR of 8.2% during the forecast year from 2024 to 2030. The overall risk factors and the disease burden remains large, thereby rendering the heart attack diagnostic sectors a profitable growth prospect. This growth is attributed to a majority of factors, such as high prevalence of coronary heart diseases, increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is resulting in a high cholesterol incidence in individuals, particularly in the rising geriatric population. However, the low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the progressively declining heart attack incidence rates are expected to hamper the market growth.

The heart attack diagnostics market has been classified by product into electrocardiogram, which measures the electrical activity of the heart; echocardiogram, a form of ultrasound test that provides images of the heart; blood tests that measure the expression of certain proteins in excess, such as troponin levels, and cardiac enzymes; and other diagnostic products. The ECG segment is expected to witness a significant growth rate in developing countries, owing to the technological advances coupled with increasing applications of ECG. Although, the increasing demand for cost effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme (CK-MB) is likely to acquire major market share in the near future. The key countries landscape included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to be the fastest growing region during the forecast period. On the other hand, North America is estimated to dominate the global heart attack diagnostics market.

Heart Attack Diagnostics Market Report Highlights:

  • North America is estimated to dominate the global heart attack diagnostics market. The increasing awareness about heart attacks, its causative and risk factors, and enhanced uptake and acceptance of technologically advanced diagnostics is expected to contribute to the market growth.
  • The Asia Pacific region is expected to be the fastest growing region during the forecast period. to The reason being the considerably large burden of heart diseases in certain developing regions, such as in India, where 2.4 million people die annually due to heart diseases. As a result of the soaring incidences of heart diseases, an urgent requirement to undertake awareness measures and incorporate advanced diagnostics is expected to fuel the market growth.
  • The Troponin segment dominated the blood tests market and accounted for a share of 62.5% in 2023. Troponin T, a protein present in the heart muscle, is crucial in diagnosing heart attacks through a high-sensitivity troponin T test.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Heart Attack Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Heart Attack Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Heart Attack Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Heart Attack Diagnostics Market: Test Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Electrocardiogram
    • 4.3.1. Electrocardiogram Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Blood Test
    • 4.4.1. Blood Test Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.1. Troponin
        • 4.4.1.1.1. Troponin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.2. CK-MB
        • 4.4.1.2.1. CK-MB Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Others
    • 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Heart Attack Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Heart Attack Diagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Others
    • 5.5.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Heart Attack Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Heart Attack Diagnostics Market Share, By Region, 2023 & 2030, USD Billion
  • 6.2. North America
    • 6.2.1. North America Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. France Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Norway
      • 6.3.8.1. Norway Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Sweden
      • 6.3.9.1. Sweden Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. China
      • 6.4.2.1. China Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. India Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Heart Attack Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Heart Attack Diagnostics Market Estimates and Forecasts, 2017 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Heart Attack Diagnostics Market Estimates and Forecasts, 2017 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GE Healthcare
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Hitachi Corporation
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Koninklijke Philips NV
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Midmark Corporation
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. F Hoffmann-La Roche Ltd
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Schiller AG
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Siemens Healthineers
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Toshiba Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Welch Allyn Inc
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Astrazaneca PLC
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives